{"id":"W2086020450","doi":"10.1007/s10637-011-9697-2","title":"Phase I study of axitinib (AG-013736) in combination with gemcitabine in patients with advanced pancreatic cancer","year":2011,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Gemcitabine; Axitinib; Medicine; Pharmacokinetics; Pancreatic cancer; Adverse effect; Internal medicine; Oncology; Pharmacology; Cancer; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002237633,0.0001587823,0.0004851827,0.0003085701,0.00002985273,0.000003806723,0.00009206157,0.00005893877,0.0002043129],"category_scores_gemma":[0.00013055,0.0001185265,0.00001604327,0.0005924728,0.0002060259,0.0001649454,0.00002234838,0.0002121808,0.000005628603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001584414,"about_ca_system_score_gemma":0.0009713313,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002936269,"about_ca_topic_score_gemma":0.0008091489,"domain_scores_codex":[0.9983611,0.00009527496,0.0004329538,0.000274579,0.000599367,0.0002367929],"domain_scores_gemma":[0.9990408,0.0001357236,0.0001737459,0.0001972356,0.000273252,0.0001791848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002905055,0.005652346,0.9829298,0.00005759989,0.00008086678,0.00001996511,0.005852328,0.00002588086,0.00005650405,0.0005221271,0.00004570977,0.001851824],"study_design_scores_gemma":[0.05189999,0.00672305,0.9385297,0.000406764,0.00009505916,0.000001968758,0.000951001,0.0002766188,0.0001926638,0.0007893493,0.00001342582,0.0001203829],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961684,0.00003989933,0.00001985265,0.0003242406,0.00001964928,0.001542223,0.00001000134,0.00001541961,0.001860326],"genre_scores_gemma":[0.996266,0.00000817301,0.002966643,0.0001528882,0.00001986021,0.00020725,0.0000798709,0.00001976909,0.0002795145],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04899493,"threshold_uncertainty_score":0.4833372,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03711149899049349,"score_gpt":0.3264996208753025,"score_spread":0.289388121884809,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}